Debt-to-equity of Kronos Bio, Inc. from 30 Jun 2021 to 31 Mar 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Kronos Bio, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2021 to 31 Mar 2025.
  • Kronos Bio, Inc. Debt-to-equity for the quarter ending 31 Mar 2025 was 36%, a 13% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Kronos Bio, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q1 2025 36% +4.2% +13% 31 Mar 2025
Q4 2024 35% +4.9% +16% 31 Dec 2024
Q3 2024 34% +6.9% +26% 30 Sep 2024
Q2 2024 34% +10% +43% 30 Jun 2024
Q1 2024 32% +11% +55% 31 Mar 2024
Q4 2023 31% +13% +73% 31 Dec 2023
Q3 2023 27% +11% +70% 30 Sep 2023
Q2 2023 23% +9.3% +65% 30 Jun 2023
Q1 2023 21% +7.8% +60% 31 Mar 2023
Q4 2022 18% +6.2% +54% 31 Dec 2022
Q3 2022 16% +5.2% +49% 30 Sep 2022
Q2 2022 14% -14% -49% 30 Jun 2022
Q1 2022 13% 31 Mar 2022
Q4 2021 11% 31 Dec 2021
Q3 2021 11% 30 Sep 2021
Q2 2021 28% 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.